Cargando…
Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors
BACKGROUND: The intimate relationship between coagulation and fibrinolysis in malignant tumors is a well-known phenomena, with the malignant phenotype enhancing coagulation and fibrinolysis. We hypothesized that soft tissue sarcoma (STS) affects the expression of coagulation and fibrinolysis markers...
Autores principales: | Asanuma, Kunihiro, Nakamura, Tomoki, Hagi, Tomohito, Okamoto, Takayuki, Kita, Kouji, Nakamura, Koichi, Matsuyama, Yumi, Yoshida, Keisuke, Asanuma, Yumiko, Sudo, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028118/ https://www.ncbi.nlm.nih.gov/pubmed/33827473 http://dx.doi.org/10.1186/s12885-021-08091-1 |
Ejemplares similares
-
Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?
por: Asanuma, Kunihiro, et al.
Publicado: (2022) -
GPR64, Screened from Ewing Sarcoma Cells, Is a Potential Target for Antibody-Based Therapy for Various Sarcomas
por: Nakamura, Koichi, et al.
Publicado: (2022) -
Prognostic Significance of Thrombomodulin mRNA in High‐Grade Soft Tissue Sarcomas after 10 years
por: Asanuma, Kunihiro, et al.
Publicado: (2020) -
Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas
por: Asanuma, Kunihiro, et al.
Publicado: (2020) -
Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
por: Nakamura, Koichi, et al.
Publicado: (2020)